Stem Cells International / 2015 / Article / Tab 4

Clinical Study

Safety of Allogeneic Umbilical Cord Blood Stem Cells Therapy in Patients with Severe Cerebral Palsy: A Retrospective Study

Table 4

Logistic regression analysis for the association between the occurrence of adverse event during allogeneic UCBSCs treatment and several predicting factors.

Predicting factorsSignificanceOdds ratio95% confidence interval
Lower boundUpper bound

Birth method
 Natural birth
Birth weight
 Low birth weight0.5030.5230.0783.484
 Normal birth weight
Gestational age
 Full term
Neonatal jaundice
Age at treatment initiation
 ≤10 years old0.03612.5431.178133.549
 >10 years old

Note. UCBSCs: umbilical cord blood stem cells; NHIE: neonatal hypoxic ischemic encephalopathy; MIDP: mother infected during pregnancy.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.